Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Sales (2022 - 2025)

Envoy Medical's Return on Sales history spans 4 years, with the latest figure at 85.13% for Q4 2025.

  • Quarterly results put Return on Sales at 85.13% for Q4 2025, up 3232.0% from a year ago — trailing twelve months through Dec 2025 was 99.0% (down 979.0% YoY), and the annual figure for FY2025 was 99.0%, down 980.0%.
  • Return on Sales for Q4 2025 was 85.13% at Envoy Medical, up from 147.12% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 99.83% in Q3 2022 to a low of 147.12% in Q3 2025.
  • The 4-year median for Return on Sales is 78.34% (2024), against an average of 65.52%.
  • The sharpest move saw Return on Sales crashed -14214bps in 2023, then surged 3232bps in 2025.
  • Year by year, Return on Sales stood at 100.44% in 2022, then grew by 30bps to 70.77% in 2023, then plummeted by -66bps to 117.45% in 2024, then grew by 28bps to 85.13% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 85.13%, 147.12%, and 73.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.